Cartilix, a Foster City, Calif.-based biotech firm that makes substances capable of repairing human tissues in joints, has sold to Biomet, an Indiana-based seller of tools and products used to help surgeons, according to PE Hub. Neither company disclosed financial terms. Cartilix previously received $6.5 million in first-round venture funding from... (Read more)
Reprinted with permission from
VentureBeat. Story copyright 2009 VentureBeat Inc. All rights reserved.
Post new comment